- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02512536
Does Botulinum A Toxin Help With Pain From Rotator Cuff Arthropathy?
Do Ultrasound Guided Botulinum A Injections Relieve Pain in Rotator Cuff Arthropathy?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Null Hypothesis This is a pilot / feasability study. The null hypothesis is that there is no effect on the pain or oxford shoulder scores reported by patients receiving a targeted botulinum A toxin injection in the presence of cuff arthropathy at 6 weeks, 3 months or 6 months compared with the baseline values.
Objectives The aim of this feasability study is to provide the necessary information for the planning of a future trial. It will test the feasibility of running such a trial and provide estimates of the differences in outcome measures and information on resource data.
All potential participants for this study will be identified by an Orthopaedic Shoulder Consultant in the shoulder clinics run at the Royal Devon and Exeter NHS Trust. The patients will be screened for eligibility by a research associate (SG). The eligibility criteria will be that the patient is medically fit for an operation, and has painful rotator cuff arthropathy, that is deemed suitable for intervention by the consultant surgeon. The patients will be informed verbally and in writing about the trial by the research associate and informed consent will be taken.
The participating patients will be allocated to an USS guided botox injection. All patients will be asked to complete a number of questionnaires prior to the injection: the Oxford Shoulder Score (OSS), a Visual Analogue Score (VAS) and the EQ-5D. The range of movement of the shoulder joint will be documented in the usual fashion.
The injections will all be done by Dr Anaspure (Consultant Radiologist) under USS guidance in a standard manner.
After the injection, patients will be reviewed using the range of movement, OSS, a patient satisfaction score and EQ-5D at 6 weeks, 3 months and 6 months post injection. A record will be kept of any complications associated with the treatment. This data will be collected by the research associate, who is independent of either intervention.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Devon
-
Exeter, Devon, United Kingdom
- Royal Devon and Exeter Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria The only eligibility criterion for participation in this study is that the patient is medically fit for an operation and diagnosed with symptomatic rotator cuff arthropathy. They must be able to give informed consent and have evidence of cuff arthropathy on plain radiographs of the affected shoulder.
Exclusion Criteria:
- Exclusion criteria Contra-indications to surgery (defined as severe cardiac impairment, e.g. heart or valve replacement, arrhythmia, previous myocardial infarction; severe respiratory impairment, e.g. chronic obstructive pulmonary disease, asthma that has required hospital admission; any other systemic medical condition that would produce a specific contraindication to a general anaesthetic).
Evidence that the patient would be unable to adhere to trial procedures or complete questionnaires, such as dementia or intravenous drug abuse Note: If a recruited patient requires a contra-lateral shoulder botox injection during the trial period, this second shoulder cannot be included in the study since the result of this intervention would not be independent from the first intervention.
Other exclusion criteria include:
Previous fractures or dislocations of the shoulder. Previous surgery on the affected shoulder. Any neurological or medical condition resulting in spasticity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Intervention: Subjects receiving a single ultrasound scan guided injection of Botulinum Toxin type A into the supraspinatus muscle belly. Drug: Dysport 300 units im. One single injection over course of study. |
Ultrasound scan guided injection into supraspinatus muscle belly with Botulinum Toxin Type A
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post injection Oxford Shoulder Scores
Time Frame: At 6 weeks, 3 months and 6 months after injection.
|
PROM
|
At 6 weeks, 3 months and 6 months after injection.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain score
Time Frame: At 6 weeks, 3 months and 6 months after injection.
|
VAS
|
At 6 weeks, 3 months and 6 months after injection.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chris Smith, Royal Devon and Exeter NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Wounds and Injuries
- Musculoskeletal Diseases
- Arthritis
- Rupture
- Shoulder Injuries
- Tendon Injuries
- Crystal Arthropathies
- Chondrocalcinosis
- Rotator Cuff Injuries
- Joint Diseases
- Rotator Cuff Tear Arthropathy
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Cholinergic Agents
- Membrane Transport Modulators
- Acetylcholine Release Inhibitors
- Neuromuscular Agents
- Botulinum Toxins
- Botulinum Toxins, Type A
- abobotulinumtoxinA
Other Study ID Numbers
- 1510150
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Tear Arthropathy
-
University of Missouri-ColumbiaCompletedShoulder Osteoarthritis | Cuff Tear Arthropathy | Massive Rotator Cuff TearUnited States
-
Zimmer, GmbHActive, not recruitingCuff-tear ArthropathyGermany, Belgium, Switzerland, United Kingdom
-
Henry Ford Health SystemSmith & Nephew, Inc.RecruitingRotator Cuff Tears | Rotator Cuff Tear ArthropathyUnited States
-
Hospital del MarRecruiting
-
Olivia C. O'ReillyActive, not recruitingRotator Cuff Tear Arthropathy | Arthropathy Shoulder | Arthritis Shoulder Glenohumoral JointUnited States
-
University of Missouri-ColumbiaHarry S. Truman Memorial Veterans HospitalWithdrawnShoulder Osteoarthritis | Rotator Cuff Tear ArthropathyUnited States
-
Fondren Orthopedic Group L.L.P.Not yet recruitingRotator Cuff Tear Arthropathy | Massive Irreparable Rotator Cuff TearUnited States
-
Schulthess KlinikArthrex, Inc.Completed
-
Istituto Ortopedico RizzoliRecruiting
-
Nova Scotia Health AuthorityActive, not recruiting
Clinical Trials on Botulinum Toxin Type A
-
AllerganTerminatedOveractive BladderSerbia, Turkey, Greece, Egypt, Lebanon, India
-
Daewoong Pharmaceutical Co. LTD.Completed
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar RhytidesUnited States
-
Brazilan Center for Studies in DermatologyCompletedWrinkles in Frontal AreaBrazil
-
HugelCompletedBenign Masseteric HypertrophyKorea, Republic of
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar Rhytides | Frown Lines Between the EyebrowsUnited States
-
Medy-ToxCompletedCervical Dystonia
-
Seton Healthcare FamilyCompleted